# Hypertonic Saline Inhalation for Nontuberculous Mycobacterial Lung Disease

> **NCT07647575** · NA · RECRUITING · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 262 (estimated)

## Conditions studied

- Nontuberculous Mycobacterial Lung Disease
- Bronchiectasis

## Interventions

- **DRUG:** Nebulized 3% Hypertonic Saline
- **DRUG:** Nebulized Normal Saline

## Key facts

- **NCT ID:** NCT07647575
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-03
- **Primary completion:** 2028-04-30
- **Final completion:** 2028-07-31
- **Target enrollment:** 262 (ESTIMATED)
- **Last updated:** 2026-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07647575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07647575, "Hypertonic Saline Inhalation for Nontuberculous Mycobacterial Lung Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07647575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*